Tempest Therapeutics Inc (TPST)

Tempest Therapeutics Inc (TPST) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $12.8M; returns 1 day -2.2%, 1 week -18.1%, 1 year -95.1%.

Tempest Therapeutics is a clinical-stage biotechnology company developing small molecule and cell-based therapies designed to target both tumor cells and the immune system. As of January 2026, the company is pre-revenue, with its economic value centered on its oncology pipeline.

Groups TPST belongs to

TPST financial model: income statement, cash flow and balance sheet